Moreover, recently reported findings revealed that the transcription factor KLF14 participates in antineoplastic effects during the development of colorectal cancer (CRC) by regulating the glycolytic enzyme LDHB, which confirmed the regulatory effect of KLF14 on glycolysis [13]. This evidence concerns the gene KLF14 and colorectal carcinoma.